Company Overview
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Company Information
- CEO
- Linda F. Powers
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 25
Contact Information
- Website
- https://www.nwbio.com
- Address
- 4800 Montgomery Lane
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 359.67M market capitalization
- Trading Volume: 902.31K shares traded today
- Price Range: 52-week range of $0.17 - $0.48
- Exchange: Listed on Other OTC
Financial Metrics
Market Analysis for Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics, Inc. (NWBO) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 359.67M, the company represents a significant player in its market. The stock is currently trading at $0.25 with a positivedaily change of 0.93%.
The company's 25 employee base and presence on the Other OTCexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -3.57, beta of -1.14, and 52-week price range from $0.17 to $0.48when evaluating investment opportunities.
Why Invest in Northwest Biotherapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (Other OTC)
- • Experienced leadership under Linda F. Powers
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.